Inventor · disambiguated record
Marc Gagnon
Also filed as: GAGNON MARC
12 granted patents·6 pending applications·68 citations·filing 2003–2024
90Inventor score
Files withBRISTOL MYERS SQUIBB CO8MERCK FROSST CANADA LTD6BLOUIN MARC1CHAU ANH1MERCK FROSST CANADA INC1
Top patents by PatentIndex Score
18 records- 0193US10047103B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 14, 2018·11 cites·22 claims
- 0292US10822343B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 3, 2020·4 cites·15 claims
- 0392US10428077B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 1, 2019·8 cites·9 claims
- 0490US9688695B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jun 27, 2017·11 cites·51 claims
- 0586US10238638B2Benzothiazole and benzothiophene compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Mar 26, 2019·4 cites·21 claims
- 0686US9862730B2Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 9, 2018·5 cites·11 claims
- 0785US2025002497A1Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0884US7960409B2Pharmaceutical phenylquinoline and chromen-2-one triazole compoundsMERCK SHARP & DOHME·Filed 2008·Granted Jun 14, 2011·8 cites·20 claims
- 0980US12084452B2Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregationBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Sep 10, 2024·0 cites·6 claims
- 1079US7442716B22-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitorsMERCK FROSST CANADA LTD·Filed 2005·Granted Oct 28, 2008·4 cites·27 claims
- 1177US7553973B2Pharmaceutical compoundsMERCK FROSST CANADA LTD·Filed 2006·Granted Jun 30, 2009·3 cites·19 claims
- 1276US7279478B2Cathepsin cysteine protease inhibitorsMERCK FROSST CANADA INC·Filed 2003·Granted Oct 9, 2007·10 cites·13 claims
- 1357US7943649B22-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitorsMERCK FROSST CANADA LTD·Filed 2008·Granted May 17, 2011·0 cites·7 claims
- 1450US2009030048A1Novel pharmaceutical compoundsBLOUIN MARC·Filed 2008·Application pending·0 cites
- 1546US2010004245A1Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturaseMERCK FROSST CANADA LTD·Filed 2007·Application pending·0 cites
- 1646US2010004287A1Cyclic Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 DesaturaseMERCK FROSST CANADA LTD·Filed 2007·Application pending·0 cites
- 1744US2009286772A12-(Phenyl or Heterocyclic)-1H-Phenanthro[9,10-D]ImidazolesCHAU ANH·Filed 2007·Application pending·0 cites
- 1844US2009118296A1Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 DesaturaseMERCK FROSST CANADA LTD·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc Gagnon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →